Protocol Design White Papers & Case Studies

  1. Completed Clinical Trials Continued To Climb In 2024 6/19/2025

    Data collected in this report reflects a shift toward sustained growth, reflecting rapid advancement in therapeutic areas such as oncology, autoimmune/inflammation, and central nervous system studies.

  2. RWD's Significance In The Largest FDA-Funded IOL Study Of Pediatric Patients 5/28/2025

    With FDA grant support, the American Academy of Ophthalmology and Verana Health conducted the largest real-world study to date on intraocular lens (IOL) use in pediatric cataract patients.

  3. Expanding The Role Of External Control Arms 5/28/2025

    External control arms (ECAs) are transforming clinical trials by enhancing efficiency, reducing costs, and addressing ethical challenges.

  4. Why EHR Data Is The Game Changer For Life Sciences Success 5/26/2025

    The pharmaceutical industry faces soaring costs and shrinking ROI. Discover why leveraging rich real-world data is now essential for driving efficiency, innovation, and competitive advantage.

  5. Accelerate Drug Development With Master Protocols 5/15/2025

    Through careful planning, aligned incentives, and an open, adaptive mindset, master protocols become powerful engines for accelerating therapies to market—particularly in high-need therapeutic areas.

  6. How Early-Stage Planning Strategies Are Optimizing Drug Development 5/12/2025

    Early integration of a target product profile (TPP) into early-stage planning is pivotal for steering drug development toward both regulatory success and commercial impact.

  7. Small Cell Lung Cancer- Global Clinical Trial Landscape (2025) 5/9/2025

    Historically dominated by chemotherapy and radiation, the treatment paradigm for small cell lung cancer (SCLC) is evolving in response to limited survival benefits and high relapse rates.

  8. Breaking Through Barriers With Integrated Trial Optimization 5/9/2025

    In today’s complex clinical trial environment, optimizing trial design requires a multidimensional strategy that balances scientific rigor with real-world constraints.

  9. What Clinical Trial Decision Makers Are Prioritizing In 2025 5/7/2025

    In 2025, clinical trial operations are undergoing a transformative shift driven by the need for speed, cost-efficiency, and patient-centered approaches.

  10. Solutions To The Challenges Of Oncology Trials 5/6/2025

    This significant Phase III trial, one of the largest global studies in head and neck cancer, faced considerable challenges including enrollment delays and an intricate study design.